Bian Dongliang, Xiong Yicheng, Jin Kaiqi, Zhu Yuming, Yu Huansha, Dai Jie, Jiang Gening
Department of Thoracic Surgery, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.
Department of Animal Experimental Center, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.
J Thorac Dis. 2023 Jan 31;15(1):54-64. doi: 10.21037/jtd-22-1010. Epub 2023 Jan 6.
The effectiveness of segmentectomy for stage IA lung adenocarcinoma (IA-LUAD) has been well-documented. However, the efficacy and safety of wedge resection for peripheral IA-LUAD remains controversial. This study evaluated the feasibility of wedge resection in patients with peripheral IA-LUAD.
Patients with peripheral IA-LUAD who underwent wedge resection by video-assisted thoracoscopic surgery (VATS) at Shanghai Pulmonary Hospital were reviewed. Cox proportional hazards modeling was performed to identify predictors of recurrence. Receiver operating characteristic (ROC) curve analysis was used to calculate the optimal cutoffs of identified predictors.
A total of 186 patients (female/male, 115/71; mean age, 59.9 years) were included. Mean maximum dimension of consolidation component (MCD) was 5.6 mm, consolidation-to-tumor ratio (CTR) was 37%, and mean computed tomography value of tumor (CTVt) was -285.4 HU. With a median follow-up of 67 months (interquartile range, 52-72 months), the 5-year recurrence rate was 4.84%. Ten patients occurred recurrence postoperatively. No recurrence was observed adjacent to the surgical margin. Increasing MCD, CTR, and CTVt were associated with a higher risk of recurrence, with corresponding hazard ratios (HRs) of 1.212 [95% confidence interval (CI): 1.120-1.311], 1.054 (95% CI: 1.018-1.092), and 1.012 (95% CI: 1.004-1.019) with optimal cutoffs for predicting recurrence of 10 mm, 60%, and -220 HU, respectively. When a tumor had characteristics under these respective cutoffs, no recurrence was observed.
Wedge resection can be considered to be a safe and efficacious management strategy for patients with peripheral IA-LUAD, especially for MCD less than 10 mm, CTR less than 60% and CTVt less than -220 HU.
肺段切除术治疗ⅠA期肺腺癌(IA-LUAD)的有效性已有充分文献记载。然而,楔形切除术治疗外周型IA-LUAD的疗效和安全性仍存在争议。本研究评估了楔形切除术治疗外周型IA-LUAD患者的可行性。
回顾性分析在上海肺科医院接受电视辅助胸腔镜手术(VATS)楔形切除术的外周型IA-LUAD患者。采用Cox比例风险模型确定复发的预测因素。采用受试者工作特征(ROC)曲线分析计算所确定预测因素的最佳截断值。
共纳入186例患者(女性/男性,115/71;平均年龄59.9岁)。实变成分的平均最大径(MCD)为5.6mm,实变与肿瘤比值(CTR)为37%,肿瘤的平均计算机断层扫描值(CTVt)为-285.4HU。中位随访67个月(四分位间距,52-72个月),5年复发率为4.84%。10例患者术后复发。手术切缘附近未观察到复发。MCD、CTR和CTVt增加与复发风险较高相关,相应的风险比(HR)分别为1.212[95%置信区间(CI):1.120-1.311]、1.054(95%CI:1.018-1.092)和1.012(95%CI:1.004-1.019),预测复发的最佳截断值分别为1mm、60%和-220HU。当肿瘤具有这些各自截断值以下的特征时,未观察到复发。
楔形切除术可被认为是外周型IA-LUAD患者的一种安全有效的治疗策略,尤其是对于MCD小于10mm、CTR小于60%和CTVt小于-220HU的患者。